Social Impact Capital specializes in investments that can deliver top decile returns in addition to a positive social impact we focus on the ''essentials of human need energy, water, food, health, environment, education, housing, access to capital, and social justice.

Social Impact Capital

SeedFolio is a seed-stage venture capital firm investing in early-stage companies with a high potential of profitable impact in life sciences and resource efficiency.

SeedFolio

Founded in 2005, True Ventures is a Silicon Valley-based venture capital firm that invests in early-stage technology startups. With more than $3.8 billion under management, True provides seed and Series A financing to entrepreneurs in some of today's growing markets.  With more than 40 team members including special advisors, operations professionals, and founders-turned-investors, True represents one of the largest and most experienced teams dedicated to the ecosystem.  The True team believes creativity flourishes when founders are supported fully and empowered to pursue brave ideas. To that end, the True Platform offers programs that inspire professional and personal growth. To date, True has helped more than 350 companies launch and scale their businesses, creating over 85,000 jobs worldwide.  True was awarded Venture Firm of the Year by the National Venture Capital Association in 2018. To learn more, visit www.trueventures.com.

True Ventures

Cantos Ventures is a pre-seed and seed-stage venture capital firm with $55M under management that invests in potentially world-changing startups, with an emphasis on climate tech, TechBio, aerospace, and next-generation computing.

Cantos

Alexandria Venture Investments is a strategic venture capital arm of Alexandria Real Estate Equities. Alexandria Venture Investments provides long-term strategic investment capital to innovative life science and technology entities developing breakthrough technologies and therapies.  Leveraging their experience and in-depth understanding of the life science and technology industries, their long-term relationships with leading investors, and their world-class scientific advisory network, they  are uniquely positioned to fund seed-, early-, and growth-stage companies.

Alexandria

Portfolia connects sophisticated investors and leaders with entrepreneurial companies. Their platform enables users to collaborate with other members and lead investors to evaluate innovative products and teams, join diligence teams, and immerse themselves in the investment process. It is an investment fund designed for women while backing innovative companies for returns and impact.

Portfolia

Exponential Impact is a mission-driven accelerator and incubator for startups at the Pre-Seed to Series A levels affiliated with the Colorado innovation economy.

Exponential Impact

Siddhi Capital is the venture partner for convention-crushing food and beverage companies. It blends deep operating knowledge and expertise through its strategic partnership with Siddhi Ops, and smart capital to propel brands forward in the food and beverage marketplace.

Siddhi Capital

SFV backs globally early-stage founders building leading Future of Food companies that are: #Cell-based #Plant-based #Recombinant

Sustainable Food Ventures

8090 Industries is a venture capital firm that partbers with global conglomerates to invest in the industrial sectors.

8090 Industries

Tiamat Sciences

Tiamat is a start-up producing affordable animal-free growth factors and biomolecules using plants as bioreactors. Thanks to its propriety platform, the company can manufacture a wide range of high-value proteins from antigens to growth factors. The company has already achieved a 10x cost reduction and at scale can get costs down 1000x even at 80% growth-margins, giving them a wide ability to price strategically. the coming years. The low investment needed to build a facility (up to 40x less than current solutions) combined with its unique technology makes Tiamat the ideal partner in production scale-up for promising markets that will soon become enormous such as cellular agriculture or cell & gene therapy.

Tiamat Sciences is a california-based biotech startup developing growth factors, cytokines, enzymes, and animal-free proteins for cellular agriculture and cell &amp; gene therapy industries. The startup has developed what it calls a “plant molecular farming platform” using transient expression vertical farming to replace bioreactors with plants, which is claimed to be 1000x cheaper than other alternatives in the market.

Making meat sustainable over the long term.

Cell-cultured Meat

Tiamat Sciences is a california-based biotech startup developing growth factors, cytokines, enzymes, and animal-free proteins for cellular agriculture and cell &amp; gene therapy industries. The startup has developed what it calls a “plant molecular farming platform” using transient expression vertical farming to replace bioreactors with plants, which is claimed to be 1000x cheaper than other alternatives in the market.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/8950">March 2022</a>, Tiamat Sciences partnered with Urban Crop Solutions, a Belgium-based vertical farming system provider, to use its vertical farming systems to grow animal free protein and to scale up its operations.Funding and financialsIn <a href="https://sp-edge.com/updates/6904">March 2023</a>, the company raised USD 2 million in a seed extension financing round. The round was led by 8090 Industries, with participation from new and existing investors. The funds were earmarked for technology development and setting up a pilot production facility in Durham, North Carolina.

Mosa Meat is a Dutch cell-cultured meat startup founded by Dr. Mark Post of Maastricht University, and was the first-ever company to produce a lab-grown meat burger. The startup produces meat by growing myosatellite cells (muscle stem cells) extracted from an animal in a bioreactor fed with a nutrient-dense medium.The company replaced the fetal bovine serum (FBS) from its growth medium in July 2020, which led to an 88x cost reduction in its medium. As of March 2024, Mosa Meat operated the Center for Advanced Meat Production, Upscaling, and Sustainability (CAMPUS), a facility spanning over 79,000 sq ft that was designed to be expandable as demand grows.In <a href="https://sp-edge.com/updates/21645">September 2023</a>, Mosa Meat became the first cultivated meat company to attain B Corp certification. The company also announced plans to apply for regulatory approval in countries worldwide.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/14175">November 2022</a>, Mosa Meat entered into an agreement with Singapore-based contract development and manufacturing organization (CDMO) Esco Aster to commercialize its cultivated beef in Singapore. Further, in <a href="https://sp-edge.com/updates/16845">March 2023</a>, the company partnered withNutreco to develop a cell feed supply chain that can expedite production and scalability while reducing cost.Funding and financialsIn its latest funding round in <a href="https://sp-edge.com/updates/28536">April 2024</a>, the company raised EUR 40 million (~USD 42.5 million) in an oversubscribed funding round co-led by Lowercarbon Capital and M Ventures, with participation from PHW Group, Invest-NL, LIOF, and LEF. The funds were earmarked for scaling production procedures, reducing production costs, and gearing up for commercialization.

Mosa Meat

Eat JUST (known as Hampton Creek prior to 2018) is a food technology company that develops and sells cultivated meat products under the “GOOD Meat” brand. In December 2020, Eat JUST received approval from the Singapore Food Agency (SFA) for its cultivated chicken product and became the first ever cell-cultured meat company to commercially sell cultivated meats. GOOD Meat also received regulatory approval from the SFA for the <a href="https://sp-edge.com/updates/15768">use of serum-free media</a> in the production of cultivated meat and was among the first two companies to receive a <a href="https://sp-edge.com/updates/17221">“no questions” letter</a> from the FDA and <a href="https://sp-edge.com/updates/19588">USDA clearance</a> for the sale of cultivated chicken in the US.The company expects to reach price parity with conventional meats by 2027 and has production facilities in Germany, the US, and Singapore. The US facility can produce up to 50,000 lbs of finished products annually, while the Singapore facility, located in JTC Bedok Food City, houses Asia’s largest bioreactor for cultivated meat production.Key customers and partnershipsEat JUST partnered with several hawker food stalls in Singapore, including <a href="https://sp-edge.com/updates/8755">Loo’s Hainanese Curry Rice</a> and <a href="https://sp-edge.com/updates/10542">Kee Eng Kee</a> (KEK) to sell its cultivated meats. In <a href="https://sp-edge.com/updates/10516">May 2022</a>, the company partnered with multinational food processing company Archer Daniels Midland (ADM) to develop a low-cost growth media with ADM to leverage its expertise and technology in optimizing GOOD Meat’s existing nutrient mix. It also <a href="https://sp-edge.com/updates/10724">partnered</a> with ABEC to build a large-scale commercial facility.Funding and financialsIn<a href="https://sp-edge.com/updates/12427"> August 2022</a>, the company bagged a USD 25 million investment along with a strategic partnership from Alibaba Group-backed private equity firm C2 Capital Partners. Together, the companies are set to work toward expanding Eat JUST’s footprint in the Chinese market. Later, in <a href="https://sp-edge.com/updates/21471">September 2023</a>, the company raised an undisclosed amount in new funding led by VegInvest/Ahimsa Foundation. The funding was to be deployed towards improving the quality and profitability of Eat JUST's products.

Eat JUST

SciFi Foods (previously Artemys Foods) is a start-up developing cell-cultured beef. The startup uses pluripotent stem cells that differentiate into muscle or fat cells, which it separates into different bioreactors to cultivate. The company plans to launch a hybrid burger made from a blend of plant-based and cell-cultured meat by 2025, pending regulatory approval. Due to complexities in mimicking the texture of beef burgers, it intends to supplant its cultivated burgers with plant-based proteins.In <a href="https://sp-edge.com/updates/11598">July 2022</a>, the company announced a breakthrough in R&amp;D which allowed them to grow beef cells in single-cell line suspension leading to a reduction in cost by more than thousand fold. The company expects to reach price parity following this milestone.In <a href="https://sp-edge.com/updates/26100">January 2024</a>, SciFi Foods completed its first large-scale production of its hybrid beef product and plans to commercialize it next year after regulatory approval.Key customers and partnershipsIn<a href="https://sp-edge.com/updates/13063"> September 2022</a>, the company partnered with Michigan State University to finalize the development and test scaling of its hybrid beef burger.Funding and financialsIn<a href="https://sp-edge.com/updates/10966"> June 2022</a>, the company raised USD 22 million in a Series A funding round led by Andreessen Horowitz(a16z). The funds were earmarked for scaling up R&amp;D, attracting new hires, and marketing strategy expenses.

SCiFi Foods

SuperMeat is a cellular agriculture startup developing cultured chicken meat. The company uses chicken cells and claims to grow them in a culture medium free from antibiotics and contaminants to develop its products. SuperMeat also operates a test kitchen known as The Chicken. It is claimed to be the world’s first farm-to-fork facility where diners can observe the production of cultivated chicken.In <a href="https://sp-edge.com/updates/21733">September 2023</a>, The Orthodox Union (OU) certified SuperMeat’s cultivated chicken as “kosher.” Further, the OU and SuperMeat will collaborate on establishing guidelines for the industry.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/9319">March 2022</a>, SuperMeat signed an MoU with PHW to supply cultivated meat products including chicken, turkey, and duck to the European market. The company also <a href="https://sp-edge.com/updates/8997">partnered</a> with Ajinomoto to set up a joint venture to accelerate the commercialization of cultivated meat while focusing on developing a cost-competitive cell growth media.&nbsp;In <a href="https://sp-edge.com/updates/11867">July 2022</a>, the company signed an MoU with Switzerland’s largest retail supermarket chain and leading meat manufacturer, Migros to expedite production and distribution of cultured meat at a commercial scale with a focus on European markets.Funding and financialsIn <a href="https://sp-edge.com/updates/10945">June 2022</a> the company received grant funding from the Israel Innovation Authority to set up what claims to be the world's largest high throughput screening system for identification and optimization of cultured meat ingredients, supplemental inputs, and cellular scaffoldings for the production of cultivated meat.

SuperMeat

Uncommon (formerly HigherSteaks) is a UK-based cell-cultured meat startup that uses cellular agriculture to grow pork from animal cells. The company leverages cellular agriculture and in-house developed RNA technologies to cultivate meat and claims its technology eliminates the need for genetic engineering and growth media.In July 2020, the company unveiled the world's first lab-grown pork belly prototype and the second cell-based bacon (behind Mission Barns cell-based bacon unveiled in early 2020). The pork belly and the bacon were produced from a combination of cell-cultured muscle and plant-based proteins and fat. Uncommon plans to commercialize its cell-cultured meat by 2022-2025, pending regulatory approval.Funding and financialsIn <a href="https://sp-edge.com/updates/19267">June 2023</a>, the company raised USD 30 million in Series A funding co-led by Balderton Capital and Lower Carbon Capital, with participation from Redalpine, East Alpha, and others. The funds were earmarked for the development of its innovative approach, expanding production, increasing the team, and initiating regulatory approvals.

Uncommon

Provide sustainable solutions for animal slaughter through the use of biotechnology

Developers of bioreactors and other technologies used in cell cultured meat production. Industrial scaling and efficiency gains are key areas of interest for the startups in the industry.

Producers of growth media for cell cultured meat production and ingredients for meat and meat analogue (cell cultured, plant-based) producers; which can include cell culture meat paste, culture fat etc. Producers of growth media, mainly focuses on startups developing alternative growth media to fetal bovine serum (FBS) using plant-based or other sources.

Tiamat Sciences

Cell-cultured Meat

Key stats

Recent Updates

Tiamat Sciences raise an extension of USD 2 million

Urban Crop Solutions supplies Tiamat Sciences with tech to grow animal-free protein

Tiamat sciences partners with vertical farming solutions company Urban Crop Solutions

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless